ABC Impact, the Singapore-headquartered private equity (PE) firm backed by Temasek, announced that it has anchored the $42-million Series D funding in Da Mi & Xiao Mi, a Chinese intervention platform for children diagnosed with Autism Spectrum Disorder (ASD).
The funding round also saw the participation of PE and venture capital firm Grand Flight Investment. Existing investors in the company include healthcare-focused investment firm OrbiMed and Chinese early growth stage healthcare investor YuanBio Venture Capital.
